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ABSTRACT 
 
World crustacean aquaculture has developed considerably since the 1980’s and is now worth more than USD 
10 billion per year. However, the economic growth of this industry has been severely affected by problems 
related to diseases and environmental degradation. Viral disease outbreaks are particularly concerning and 
have caused massive economic losses around the world. However, there is still no effective treatment for 
most viral diseases. Current research on crustacean diseases focuses on the role of innate immune system as 
the first defence mechanism against viral infections. Of the available antiviral immune responses, interferons 
(IFNs) are known to have ability interfering effect on viral replication, particularly in vertebrates. This paper 
reviews the function and molecules involved in the vertebrate interferon system and whether similar 
molecules and pathways may exist in crustacean immune systems. Therefore, IFN or IFN-like proteins in 
crustaceans may provide the key to managing viral diseases.  
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INTRODUCTION 
 
Global crustacean aquaculture is one of the 
most economically important sectors that is 
worth more than $US10 billion per annum 
(Johnson, et al., 2008). Approximately 75% of 
the world’s production of farmed shrimp comes 
from Asian countries, particularly from China 
and Thailand followed by Vietnam, Indonesia, 
and India (McClennan, 2004) providing income 
to rural communities and the developing 
economic sector (Johnson, et al., 2008).  
Currently, shrimp production continues 
to suffer from problems related to 
environmental devastation and diseases, both 
infectious and non-infectious (Bachère, 2000) 
that have caused massive losses to shrimp 
aquaculture industries throughout its 40-year 
existence. Farmed shrimp are susceptible to a 
wide variety of pathogens, including protozoa, 
fungi, bacteria, and viruses (Johnson, et al., 
2008), particularly from the introduction of 
wild broodstock. The main contributors to these 
losses were viral diseases (Lotz, 1997). Due to 
their epizootic spread and economic impact, 
white spot syndrome virus (WSSV), yellow 
head virus (YHV), taura syndrome virus (TSV), 
infectious hypodermal and haematopoietic 
necrosis virus (IHNNV) (OIE, 2003), and 
recently infectious myonecrosis virus (IMNV) 
(Tang, et al., 2005) have caused substantial 
losses within aquaculture facilities (Table 1). 
Over 20 different shrimp viruses has 
been recorded and many of these have spread 
through farms and have several host species 
(McClennan, 2004). Water is the main transfer 
vector of many of these viruses and high 
stocking densities are thought to increase the 
rate of the spread of a virus (NCFE, 1999). 
Consequently, any virus outbreak also carries 
the risk of decimating shrimp living in the wild. 
Viral diseases are also thought to spread by the 
movement of live and frozen shrimp through 
import-export activities (Dhar, et al., 2001).  
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Table 1. List of crustacean viral diseases that have caused significant losses in aquaculture 
 
Diseases Gross Signs Organisms Reference 
WSSV 
White circular, inclusions or spots in the cuticle, often 
accompanied by red coloration in overall body. 
Stop eating followed by swimming near the surface at 
pond edges. 
Penaeus monodon 
Litopenaeus. vannamei 
OIE, 2003 
YHV 
Yellow in cephalothorax and general bleaching of body 
colour. Moribund shrimp congregated near the surface 
the edge of ponds. 
P. monodon   
L. vannamei  
L. stylirostrus 
Farfantepenaeus aztecus 
F. duorarum 
OIE, 2003 
TSV 
Black cuticular lesions and loose 
shell in P. Monodon 
Expansion of the red chromatophores cause overall 
pale reddish coloration, tail fan and pleopods distinctly 
red 
Having soft shells, an empty gut and often in the late D 
stages of the molt cycle. 
Hypoxic on affected shrimp and swim to the pond 
surface, looking for higher level of DO 
P. monodon  
L. vannamei 
L. stylirostris 
 
Lightner et 
al., 1995; 
OIE, 2003; 
Limsuwan 
& Churchid, 
2007  
IHHNV 
In L. stylirostris have white coloured spots in the 
cuticular epidermis, especially at the junction of the 
tergal plates of the abdomen, giving such shrimp a 
mottled appearance. 
Juvenile L. vannamei with RDS display bent or 
deformed rostrums, wrinkled antennal flagella, 
cuticular roughness, and other cuticular deformities. 
P. monodon  
L. vannamei 
L. stylirostris 
OIE, 2003 
IMNV 
The appearance of whitish, opaque lesions in the 
skeletal muscle, and infected shrimp eventually 
become 
lethargic.  
P. monodon  
L. vannamei 
L. stylirostris 
Tang et al., 
2005 
 
Development of treatments for 
crustacean viral diseases 
 
Most viral diseases cannot be treated effectively 
in crustacea since it is common for crustacea, 
such as shrimp to be infected by viruses without 
any apparent symptoms (Flegel, et al., 2004). 
Crustacea do not have an adaptive immune 
response that enables them to recognise 
previous exposure to pathogens (Johnson, et al., 
2008). Consequently, vaccines are unable to be 
used as a method of prevention for crustacea. 
Preventing and controlling disease outbreaks 
lies in strengthening the innate immune 
response to viral diseases. However, the 
molecular mechanisms involved in antiviral 
immune responses remain unknown for the 
majority of crustacean species. Of the available 
antiviral immune responses, interferons (IFNs) 
are particularly interesting because of their 
ability to interfere in viral replication (Stark, et 
al., 1998). Since the recent increase in the 
commercial production of human interferons, 
there is the possibility of using human 
interferons in antiviral therapy for crustacea. It 
may also be possible to use interferons that are 
present in the innate immune system of 
crustacea for treatment of viral infections since 
all living cells appear to be able to produce 
interferons (Sanders, 1981). In fact, information 
on any interferon-based antiviral system in 
crustacea which resembles or has functions 
similar to that of vertebrates is poorly 
understood. This is irrespective of a number of 
processes of the antiviral system being 
identified in crustacea, such as the innate 
immune response from Toll homolog in 
Chinese shrimp Fenneropenaeus chinensis  
(Yang, et al., 2008) and the activation of the 
signal transducers and activators of 
transcription (STAT) in response to WSSV 
infection (Chen, et al., 2008; Liu, et al., 2009). 
In light of these studies, this review attempted 
to build an understanding of antiviral systems in 
crustacea. Expanding knowledge of any 
interferon-based antiviral system in crustacea 
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may provide the link of antiviral immunity 
between vertebrates and invertebrates, as well 
as aid in developing treatments for viral 
infections in crustacea. This review will discuss 
the interferon system, the induction of type I 
IFNs and their pathways (focusing on interferon 
alpha and interferon beta) during antiviral 
immune response in vertebrates. Finally, this 
review will discuss evidence for several parts of 
interferon-based antiviral system in crustacean 
that may facilitate the general understanding if 
IFN or IFN-like proteins do exist in crustacea.  
 
Interferon as an Antiviral Immune 
Response 
 
Introduction to the interferons system 
 
Interferons (IFNs) are  a type of glycoprotein 
called cytokines that were first described for 
their interfering effect on viral replication 
(Issacs and Lindenmann, 1957). Later on, IFNs 
were shown to possess a wide range of 
biological activities (Biron and Sen, 2001) such 
as growth of cells, differentiation, apoptosis and 
modulation of the immune response (Samuel, 
2001).  
In the first line of defence against 
pathogens such as viruses, bacteria or parasites 
in vertebrates, antigen-presenting cells such as 
macrophages and dendritic cells detect the 
invading pathogens via pattern recognition 
receptors (PRRs) including membrane-
associated Toll-like receptors (TLRs) (Kawai 
and Akira, 2007). These receptors recognise 
conserved pathogen-associated molecular 
patterns (PAMPs) that are present in microbial 
proteins, nucleic acids, lipids and carbohydrates 
(Smith, et al., 2005). The main signalling of the 
IFN pathways involves specific receptors 
binding to the Janus kinases (JAKs), signal 
transducers and activators of transcription 
(STATs) followed by inducing expression of 
many genes that establish the responses (Stark, 
et al., 1998). IFN-treated cells synthesise IFNs 
in response to viral infection by conferring an 
antiviral state to the cells (Samuel, 2001; Stark, 
et al., 1998).  
IFNs are separated into three groups 
based on affinity and activation of their 
receptors (Galligan, et al., 2006): type I, type II 
(Smith, et al., 2005) and type III (Zhou, et al., 
2007). Type I IFN consist of 13 α-genes 
encoding 12 IFN-α subtypes, one β-gene 
encoding a single IFN-β subtype, a single IFN-
ω gene encoding IFN-ω (Mogensen, et al., 
2004; Smith, et al., 2005), IFN-ε, IFN-κ and 
IFN-υ (Pestka, 2007). Type I IFNs are 
commonly found in mammals and bind to a 
specific type of cell receptor known as 
interferon alpha receptor (IFNΑR) while IFN γ 
binds to a specific type of receptor known as 
interferon gamma receptor (IFNGR). Type II 
IFN consists of a single gene that codes for the 
cytokine IFN-γ (Smith, et al., 2005). Type III 
IFN consists of IFN-λ molecules (IFN-λ1-3) 
and its isoforms (IL-28A, IL-28B and IL-29) 
that bind specifically to a heterodimeric 
receptor consisting of the interleukin 10 
receptor (IL10R2) and class II cytokine receptor 
subunit interferon lambda receptor 1 (IFNLR1) 
(Lindahl, 2006; Smith, et al., 2005; Vilcek, 
2003). 
 
Induction of type I Interferon 
 
The important role of infectious agents in 
initiating the induction of IFN is becoming 
clear with the knowledge of TLR signalling in 
humans (Smith, et al., 2005). TLRs are 
membrane-associated receptors that 
characterise an initial detection and response to 
pathogens, such as the nematode 
Caenorhabditis elegans (Fallon, et al., 2001). 
So far, there are 11 known TLRs and each of 
them has a number of ligands indicating 
potential binding sites and act as integrators of 
signalling with other receptors (Smith, et al., 
2005). Some TLRs can change their properties 
to bind different ligands known as homo or 
heterodimers (Smith, et al., 2005). Lipid-based 
structures are recognised by TLR2 (bacterial or 
spirochetal lipoproteins and peptidoglycan) in 
combination with TLR1 or TLR6 as 
heterodimers and TLR4 as a homodimer. Viral 
and or bacterial nucleic acids are recognised by 
TLR3 (double stranded RNA (dsRNA)), TLR7 
and TLR8 (single stranded RNA (ssRNA)), and 
TLR9 (CpG motifs in DNA). Protein from 
pathogens such as flagellin are recognised by 
TLR5 and profilin are recognised by TLR 11 
(but only in mice) (O'Neill, 2006; Smith, et al., 
2005; Yarovinsky, et al., 2005).  
All TLRs, except TLR3, use the general 
adaptor protein MyD88 that is responsible for 
signal transduction (Fitzgerald, et al., 2001) 
(Fig. 1). The TLRs and interleukin 1 receptor 
(IL-1R) family share conserved cytoplasmic 
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regions called the Toll-interleukin receptor 
(TIR) domains (Smith, et al., 2005). The TIR 
domain on the cytoplasmic region of the TLRs 
interacts with the carboxy-terminal TIR of 
MyD88 allowing a downstream signalling 
pathway (Imler and Hoffmann, 2003). The 
serine-threonine kinase IL-1R associated kinase 
1 (IRAK1), IRAK2 and IRAK4 are involved in 
signal transduction between MyD88 and tumor 
necrosis factor receptor (TNFR)-associated 
factor 6 (TRAF6) (Fig. 1) (Suzuki, et al., 2002). 
Serine-threonine activation is linked to the 
activation of protein kinases such as the 
mitogen activating protein (MAP) kinase 
family, leading to activation of TAK1 which 
regulates p38 and the JNK activation pathways 
(Lee, et al., 2000) that are linked to 
programmed cell death AP-1 (Fig. 1). TAK1 
activation also discharges IκB releasing NF-κB 
to bind to the promoters of proinﬂammatory 
cytokines (Fig. 1), such as alpha (TNF-α), IL-6, 
and IL-12 (Smith, et al., 2005). Although IL-6 
alone does not stimulate the expression of 
Interferon Stimulated Genes (ISG), it improves 
the cellular response to IFN-α  (Weihua. et al., 
2000) via a separate pathway. 
Besides MyD88, there is an additional adaptor 
allowing the lipopolysaccharide (LPS) 
signalling cascade which leads to the activation 
of the MAP kinase family and NF-κB (Kawai, 
et al., 1999). TLR2 and 4 have this adaptor 
molecule in common referred to as, TIR-
containing adaptor protein (TIRAP) (Fig. 1). 
Furthermore, identification of a third adaptor 
protein called Toll/IL-1 receptor domain-
containing adaptor inducing IFN-β (TRIF) 
(Yamamoto, et al., 2002), also known as Toll-
interleukin 1 receptor domain (TIR)-containing 
adaptor molecule 1 (TICAM1) is essential for 
the TIRAP independent pathway (Oshiumi, et 
al., 2003a; Oshiumi, et al., 2003b). Over 
expression of TRIF plays a crucial role in 
activation of the NF-κB-dependent promoter 
but unlike MyD88 or TIRAP, TRIF activates 
IFN-β expressed by the signalling pathway 
through TLR3 and TLR4 (Yamamoto, et al., 
2002). In general, there are two major pathways 
of initiating IFN induction by TLRs (Smith, et 
al., 2005). 
 
 
 
Fig. 1. Illustration of innate immune response involving Pattern Recognition Receptors (PRRs) and 
membrane-associated Toll-like Receptors (TLRs) (R&DSystems, 2009). 
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Fig.2. The two related pathways of induction of type I IFN (IFN-α and IFN-β). Initially, the induction of IFN-
β begins with the activation of IRF3 and NF-κB stimulated by MyD88 and TRIF adaptors via TLR3 
and TLR4. Secondly, IFN-β autocrinely stimulates the IFNAR resulting in the activation of the 
JAK-STAT pathway forming ISGF3 and IRF9 to promote the transcription of the IRF7 gene. IRF9, 
IRF7 and ISGF3 induce the production of IFN-α and prolongs the IFN response as well as encoding 
IFN-induced proteins, such as PKR, OAS and Mx proteins. Modified from Smith, et al., (2005). 
 
The JAK-STAT pathway 
 
The JAK-STAT pathway of IFN-α and IFN-β 
requires two receptor subunits (IFNAR1 and 
IFNAR2), two Janus kinase (JAK) family of 
tyrosine kinases (Tyk2 and JAK1), two signal 
transducers, two transcription activators 
(STAT1 and STAT2), and the IRF family 
transcription factor p48 (IRF9) (Stark, et al., 
1998). Both IFN-α and IFN-β interact with 
Tyk2 and JAK1, leading to the phosphorylation 
of interferon alpha-receptor (IFNARs) which 
allows STAT2 to bind to it. This stimulates the 
phosphorylation of STAT2 generating a binding 
site for STAT1, resulting in the formation of 
STAT1-STAT2 heterodimer after dissociation 
from the receptor (Leung, et al., 1995). This 
dimer migrates to the nucleus where it binds to 
the promoter region of the IFN genes 
(IRF9/p48) and forms a transcription complex, 
referred to as interferon-stimulated gene factor 
3 (ISGF3) (Leonard and Sen, 1997). This 
facilitates transcription of the interferon-
stimulated genes (ISGs) by binding to the 
interferon-simulated response element (ISRE) 
(Fu, et al., 1990). The ISRE is a response 
element for genes stimulated by IFN-α (Fu, et 
al., 1990). Type I IFN regulate pleiotropic 
effects as a result of infectious pathogens; 
typically the ability to confer an antiviral state 
(Stark, et al., 1998). An antiviral state 
established in an infected cell inhibits protein 
synthesis and stimulates apoptosis reducing the 
capability of the invading virus to replicate. 
Hence, the rate of spread of infections also 
reduced (Smith, et al., 2005).  
 
Interferon-induced proteins 
 
There are many antiviral responses regulated by 
IFNs through the transcription of several 
hundred genes (Levy and García-Sastre, 2001). 
The family of IFN-inducible genes is capable of 
encoding proteins, such as RNA-dependent 
protein kinase (PKR), oligoadenylate synthetase 
(OAS) and Mx proteins. PKR has the capability 
of inhibiting transcription by preventing viral 
replication via phosphorylation of the initiation 
factor eIF. This is different to the Mx proteins 
that interfere with viral replication by inhibiting 
viral polymerases (Stark, et al., 1998).  
The Oligoadenylate Synthetase (OAS)  pathway 
consists of several enzymes encoded by 
multiple genes (Levy and García-Sastre, 2001). 
The role of the OAS pathway in the IFN-
induced antiviral responses is supported 
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through genetic manipulation of RNase L 
where its over-expression has been documented 
to inhibit vaccinia virus and HIV-1 replication 
(Stark, et al., 1998). Besides facilitating an 
antiviral role, OAS also plays an important role 
in controlling cell growth and is effective in the 
regulation of several apoptotic pathways 
(Rebouillat and Hovanessian, 1999; Stark, et 
al., 1998).    
Myxovirus-resistance (Mx) proteins are 
members of IFN-inducible genes of the 
dynamin-like GTPases (Samuel, 2001). They 
have the capability to block the replication 
cycle of a wide range of viruses in the early 
stage of infection (Haller, et al., 2007). In 
addition, the range of antiviral activities of the 
Mx proteins is dependent on the speciﬁc Mx 
protein, its cellular site of localisation, and the 
type of virus (Samuel, 2001). Not all of these 
proteins have antiviral activity, but some do 
provide a resistant state to several RNA viruses 
when expressed in cells (Levy and García-
Sastre, 2001). Specifically, IFN-α or IFN-β 
appear to be the most important regulators of 
the antiviral mechanism by Mx proteins 
(Simon, et al., 1991). Mx proteins are a very 
sensitive marker for IFN actions (Gresser, et 
al., 1988; Haller, et al., 2007).  
 
Evidence of Interferon-based Antiviral 
System in the Crustacea 
 
Information concerning immune mechanisms 
directed against virus infections in invertebrates 
is limited. In fact, there are a lack of genes 
homologous to IFNs or to the main effectors 
that induce IFN responses, such as RNA-
dependent protein kinase (PKR) (Robalino, et 
al., 2004) in complete genome sequences of 
Drosophila melanogaster  (Adams, et al., 2000) 
and Anopheles gambiae (Holt, et al., 2002). 
This is interesting, since invertebrates have 
several parts of interferon-based antiviral 
system described to be analogous to those 
present in vertebrates. 
A number of other antiviral immune 
responses also have been described in 
crustacea. Antiviral activity that inhibits a 
variety of DNA and RNA viruses such as 
Sindbis virus, vaccine virus, vesicular stomatitis 
virus, mengo virus, banzi virus and 
poliomyelitis has been found in tissue extracts 
of the blue crab, shrimp and crayfish (Pan, et 
al., 2000). Other studies proposed a number of 
immune responsive proteins/genes involved in 
WSSV pathogenesis in shrimp and crayfish 
(Dhar, et al., 2003; He, et al., 2005; Liu, et al., 
2006; Pan, et al., 2005; Rojtinnakorn, et al., 
2002; Roux, et al., 2002). Antibodies against 
WSSV envelope proteins, such as VP28 
(Witteveldt, et al., 2004a; Witteveldt, et al., 
2004b, VP68, VP281 and VP466 (Wu, et al., 
2005) prolong the survival of the shrimp after 
WSSV challenge (Liu, et al., 2009). More 
studies are needed to determine the capability 
of these antibodies against the other viral 
proteins. A few other immune stimulants, such 
as bacterial lipopolysaccharide (Takahashi, et 
al., 2000), glucans derived from fungi (Chang, 
et al., 2003; Huang and Song, 1999), dsRNA 
(Robalino, et al., 2007; Robalino, et al., 2005; 
Robalino, et al., 2004), and inactivated viruses 
(Bright, et al., 2005; Melena, et al., 2006) have 
also been described to elicit an antiviral 
immune response in crustacea.   
There is some evidence for the role of 
an interferon-based antiviral system in 
crustacea. Firstly, double-stranded RNA 
(dsRNA) was found  to actively induce an 
antiviral responses against two unrelated 
viruses, TSV and WSSV under controlled 
experimental conditions in Litopenaeus 
vannamei (Robalino, et al., 2004). Similarly, 
interferon responses in vertebrates are also 
triggered by dsRNA. Secondly, IFN systems in 
vertebrates have TLRs as receptors that 
recognise microbes during infection (Akira, et 
al., 2006). A Toll homologous to vertebrate 
TLRs was described from the Chinese shrimp 
Fenneropenaeus chinensis (FcToll) following 
bacterial and viral stimulation (Yang, et al., 
2008). The role of FcToll in the innate immune 
response may possess a similar role to dToll in 
Drosophila, although dToll does not act as the 
Pattern Recognition Receptor (PRR) in the host 
defence system (Hu, et al., 2004). Recently, 
PmToll and lToll from Penaeus monodon and 
L. vannamei respectively have been described 
(Arts, et al., 2007; Yang, et al., 2007). 
However, their function in shrimp innate 
immunity against pathogens remains unclear.  
IRF family members which are major 
regulators of a hosts defence in vertebrates (by 
the induction of IFN) (Tamura, et al., 2008) are 
also present in all principal metazoan groups. 
One IRF gene has also been described from the 
Chinese mitten crab (Eriocheir  sinensis) 
(Nehyba, et al., 2009). Furthermore, the 
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JAK/STAT system that is involved in signal 
transduction following cell activation by IFNs, 
has a crucial role in blocking viral infection in 
Drosophila (Lemaitre and Hoffmann, 2007) 
and mosquitoes (Lin, et al., 2004). In shrimp, 
STAT is activated in the response to WSSV 
infection and the activated STAT switches on 
the promoter gene allowing viral transcription 
in the nucleus (Chen, et al., 2008; Liu, et al., 
2009).  
Overall evidence suggest that 
interferon-based antiviral system, analogous to 
those present in vertebrates, may exist in 
shrimp and that innate antiviral immunity in 
vertebrates is possibly linked with invertebrate 
innate immunity (Robalino, et al., 2004). 
However, conclusive evidence of the existence 
of IFNs in crustacea remains elusive. A few 
studies (He, et al., 2005; Mai, et al., 2009) 
describe a recombinant interferon-like protein 
from the virus-resistant shrimp (Marsupenaeus 
japonicus). However, Rosa and Barracco 
(2008) dispelled these claims and argued that 
the molecule was only a portion of the 
mitochondrial F0-ATP synthase rather than an 
interferon.  
 
Mechanism Model of Interferon-based 
Antiviral System in Crustacea 
 
Based on current evidence for interferon-based 
antiviral system in crustacea, a model for the 
mechanism of interferon has been proposed 
(Fig. 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. A hypothetical model for the mechanism of IFN in crustacea. Innate immune response in crustacea 
may present after viral stimulation that is recognised by Toll homolog receptors, such as FcToll from 
Fenneropenaeus chinensis, PmToll from Penaeus monodon and lToll from Litopenaeus vannamei. 
The next pathways remain unknown until an IRF gene was found as a major regulator of host 
defences through the induction of IFN 
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This model simplifies pathway of interferon-
based antiviral induction in crustacea including 
several molecules that responsible to induce 
interferon. Firstly, invasion by a virus activates 
innate antiviral responses by Toll homolog 
receptors containing TIR domains (Yang, et al., 
2008; Yang, et al., 2007). The activated IRF 
gene then encodes transcription factors 
(possibly by the induction of interferon) that are 
important in immune defences (Nehyba. et al., 
2009). Finally, the JAK/STAT pathway 
activates the promoter genes allowing viral 
transcription. 
 
Conclusion and Future Studies 
 
Innate immune responses against microbes such 
as bacteria, fungi, and viruses in crustacea have 
been identified in crayfish, crabs, lobster and 
shrimp (Liu, et al., 2009). Among other innate 
immune responses, interferons are increasingly 
becoming the focus in investigations of the 
antiviral system in crustacea. Although 
interferons homologous to vertebrates have not 
yet been demonstrated in any crustacea, parts of 
an interferon-based antiviral system resembling 
the functions of interferons in vertebrates have 
been described. These observations are 
consistent with the presence of interferons or 
interferon-like proteins in crustacea. Therefore, 
instead of the IFN homology issue, focusing on 
the analogous functions of IFNs could be the 
key to understanding the evolution of antiviral 
immunity at the molecular level. Further 
evidence of similar molecules and pathways of 
interferons, would allow the development of 
novel strategies and therapies to control viral 
diseases in crustacean aquaculture. 
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